From the Autonomic and Neuroendocrinological Laboratory Dresden (M.R., T.Z.), Department of Neurology, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; Department of Epidemiology and Public Health (M.H.), University College London, London, UK; Hypertension in Africa Research Team (N.T.M., L.M.), School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom, South Africa; Neurovascular Hypertension & Kidney Disease (M.P.S.) and Human Neurotransmitters Laboratories (G.W.L.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; and Department of Experimental and Clinical Pharmacology and Toxicology (R.H.B.), University Medical Center-Hamburg Eppendorf, Hamburg, Germany.
Address correspondence and reprint requests to Manja Reimann, PhD, Autonomic and Neuroendocrinological Laboratory Dresden, Department of Neurology, University Hospital Carl Gustav Carus at the Dresden University of Technology, Fetscherstr. 74, 01307 Dresden, Germany. E-mail: [email protected]
Received for publication January 17, 2013; revision received June 14, 2013.
